Pierre F. Dodion
Corporate Officer/Principal chez American Society of Clinical Oncology, Inc.
Profil
Pierre F.
Dodion currently works at American Society of Clinical Oncology, Inc., as Member.
Dr. Dodion also formerly worked at Pfizer Inc., as Executive Director-Oncology from 2006 to 2007, Aventis SA, as Senior Medical Director from 1997 to 2002, Novartis AG, as Executive Director-Global Strategy & Marketing from 2002 to 2006, ARIAD Pharmaceuticals, Inc., as Senior Vice President-Corporate Development from 2011 to 2012, Innate Pharma SA, as Chief Medical Officer & Executive VP from 2014 to 2020, and Nordic Nanovector ASA, as Chief Medical Officer.
Dr. Dodion received his Masters Business Admin degree from St. Joseph's University and doctorate degree from Université Libre de Bruxelles.
Postes actifs de Pierre F. Dodion
Sociétés | Poste | Début |
---|---|---|
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Corporate Officer/Principal | - |
Anciens postes connus de Pierre F. Dodion
Sociétés | Poste | Fin |
---|---|---|
INNATE PHARMA | Chief Tech/Sci/R&D Officer | 16/07/2020 |
PFIZER, INC. | Corporate Officer/Principal | 01/01/2007 |
NOVARTIS AG | Sales & Marketing | 01/01/2006 |
Aventis SA
Aventis SA Pharmaceuticals: MajorHealth Technology Aventis SA develops pharmaceuticals and vaccines for preventative medicine. The company is located in Schiltigheim, France. | Chief Tech/Sci/R&D Officer | 01/01/2002 |
THOR MEDICAL | Chief Tech/Sci/R&D Officer | - |
Formation de Pierre F. Dodion
St. Joseph's University | Masters Business Admin |
Université Libre de Bruxelles | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 3 |
---|---|
PFIZER, INC. | Health Technology |
NOVARTIS AG | Health Technology |
INNATE PHARMA | Health Technology |
Entreprise privées | 4 |
---|---|
ARIAD Pharmaceuticals, Inc.
ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA. | Health Technology |
Aventis SA
Aventis SA Pharmaceuticals: MajorHealth Technology Aventis SA develops pharmaceuticals and vaccines for preventative medicine. The company is located in Schiltigheim, France. | Health Technology |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Health Services |
Nordic Nanovector ASA
Nordic Nanovector ASA Pharmaceuticals: MajorHealth Technology Nordic Nanovector ASA is a biopharmaceutical company, which engages in the development, marketing, and sale of medical products and equipment for anticancer therapeutics for haematological cancers. The firm offers the Betalutin which is an antibody radionuclide conjugates for the treatment of non-Hodgkin lymphoma. It operates through the following geographical segments: Norway, Switzerland, and the United Kingdom. The company was founded by Roy Hartvig Larsen, Oyvind Sverre Bruland, and Jostein Dahle on July 2, 2009 and is headquartered in Oslo, Norway. | Health Technology |